{"transactions":[{"id":1388773,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-09T11:46:52.000Z","date":"2024-10-08","kind":"purchase","planned":false,"acquired":true,"shares":5431,"price":0.9099,"value":4941.6669,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-18 reverse stock split effective April 19, 2024."}],"balance_after":8638,"source":{"system":"sec-edgar","filing":"0001437749-24-030918","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924030918/rdgdoc.xml","form_type":"4"}},{"id":1449619,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2024-07-24T21:28:26.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":2674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 2,674 warrants to purchase 2,674 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 2,674 warrants to purchase 2,674 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 2,674 warrants to purchase 2,674 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."}],"balance_after":2674,"derivative":{"exercise_price":4.11,"underlying":"Common Stock","underlying_shares":2674},"source":{"system":"sec-edgar","filing":"0001437749-24-023368","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924023368/rdgdoc.xml","form_type":"4"}},{"id":1449618,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Series C Preferred Stock","published_at":"2024-07-24T21:28:26.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":13,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 13 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 13 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 13 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 13 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."}],"balance_after":13,"derivative":{"underlying":"Common Stock","underlying_shares":3471},"source":{"system":"sec-edgar","filing":"0001437749-24-023368","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924023368/rdgdoc.xml","form_type":"4"}},{"id":1449617,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Warrants (Right to Buy)","published_at":"2024-07-24T21:27:47.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":4011,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."}],"balance_after":4011,"derivative":{"exercise_price":4.11,"underlying":"Common Stock","underlying_shares":4011},"source":{"system":"sec-edgar","filing":"0001437749-24-023367","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924023367/rdgdoc.xml","form_type":"4"}},{"id":1449616,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Series C Preferred Stock","published_at":"2024-07-24T21:27:47.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":19,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."}],"balance_after":19,"derivative":{"underlying":"Common Stock","underlying_shares":5073},"source":{"system":"sec-edgar","filing":"0001437749-24-023367","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924023367/rdgdoc.xml","form_type":"4"}},{"id":1772323,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-28T11:24:59.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.0199,"value":2549.75,"ownership":{"direct":true},"balance_after":57877,"source":{"system":"sec-edgar","filing":"0001437749-23-026969","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923026969/rdgdoc.xml","form_type":"4"}},{"id":1772842,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-27T11:34:59.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.9,"value":2250.0,"ownership":{"direct":true},"balance_after":55377,"source":{"system":"sec-edgar","filing":"0001437749-23-026828","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923026828/rdgdoc.xml","form_type":"4"}},{"id":1794523,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":90815,"kind":"person","name":"Geffken Daniel E.","position":1,"cik":"0001314756","reported_name":"Geffken Daniel E.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-29T20:37:19.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":3050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":3050,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0001437749-23-024844","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024844/rdgdoc.xml","form_type":"4"}},{"id":1794522,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":90815,"kind":"person","name":"Geffken Daniel E.","position":1,"cik":"0001314756","reported_name":"Geffken Daniel E.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-29T20:37:19.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":2175,"source":{"system":"sec-edgar","filing":"0001437749-23-024844","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024844/rdgdoc.xml","form_type":"4"}},{"id":1796875,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-25T22:03:42.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":3050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":3050,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0001437749-23-024716","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024716/rdgdoc.xml","form_type":"4"}},{"id":1796874,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-25T22:03:42.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":2133,"source":{"system":"sec-edgar","filing":"0001437749-23-024716","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024716/rdgdoc.xml","form_type":"4"}},{"id":1796872,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":32291,"kind":"person","name":"Strobeck Mark","position":1,"cik":"0001599219","reported_name":"Strobeck Mark","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-25T22:03:00.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":3450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":3450,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":3450},"source":{"system":"sec-edgar","filing":"0001437749-23-024715","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024715/rdgdoc.xml","form_type":"4"}},{"id":1796871,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":32291,"kind":"person","name":"Strobeck Mark","position":1,"cik":"0001599219","reported_name":"Strobeck Mark","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-25T22:03:00.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0001437749-23-024715","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024715/rdgdoc.xml","form_type":"4"}},{"id":1796870,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110230,"kind":"person","name":"SCOTT ROBERT A","position":1,"cik":"0001248520","reported_name":"SCOTT ROBERT A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-25T22:01:54.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":3050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":3050,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0001437749-23-024714","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024714/rdgdoc.xml","form_type":"4"}},{"id":1796869,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110230,"kind":"person","name":"SCOTT ROBERT A","position":1,"cik":"0001248520","reported_name":"SCOTT ROBERT A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-25T22:01:54.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":2133,"source":{"system":"sec-edgar","filing":"0001437749-23-024714","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024714/rdgdoc.xml","form_type":"4"}},{"id":1796868,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-08-25T22:01:01.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":23800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":23800,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":23800},"source":{"system":"sec-edgar","filing":"0001437749-23-024713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024713/rdgdoc.xml","form_type":"4"}},{"id":1796867,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-25T22:01:01.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":15867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":17440,"source":{"system":"sec-edgar","filing":"0001437749-23-024713","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024713/rdgdoc.xml","form_type":"4"}},{"id":1796866,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110229,"kind":"person","name":"Curtis Eric","position":1,"cik":"0001651755","reported_name":"Curtis Eric","relationship":{"officer":true,"officer_title":"SVP & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-08-25T22:00:05.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":22000,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001437749-23-024712","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024712/rdgdoc.xml","form_type":"4"}},{"id":1796865,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110229,"kind":"person","name":"Curtis Eric","position":1,"cik":"0001651755","reported_name":"Curtis Eric","relationship":{"officer":true,"officer_title":"SVP & COO"}}],"security":"Common Stock","published_at":"2023-08-25T22:00:05.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":14667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":15920,"source":{"system":"sec-edgar","filing":"0001437749-23-024712","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024712/rdgdoc.xml","form_type":"4"}},{"id":1796864,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-08-25T21:55:17.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":68800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":68800,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":68800},"source":{"system":"sec-edgar","filing":"0001437749-23-024710","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024710/rdgdoc.xml","form_type":"4"}},{"id":1796863,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-25T21:55:17.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":45867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":52877,"source":{"system":"sec-edgar","filing":"0001437749-23-024710","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024710/rdgdoc.xml","form_type":"4"}},{"id":1912675,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-27T11:41:36.000Z","date":"2023-04-26","kind":"purchase","planned":false,"acquired":true,"shares":1497,"price":1.77,"value":2649.69,"ownership":{"direct":true},"balance_after":7010,"source":{"system":"sec-edgar","filing":"0001437749-23-011245","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923011245/rdgdoc.xml","form_type":"4"}},{"id":1913598,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-26T11:21:45.000Z","date":"2023-04-25","kind":"purchase","planned":false,"acquired":true,"shares":1315,"price":1.89,"value":2485.35,"ownership":{"direct":true},"balance_after":5513,"source":{"system":"sec-edgar","filing":"0001437749-23-011064","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923011064/rdgdoc.xml","form_type":"4"}},{"id":1981064,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T01:28:30.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":1573,"source":{"system":"sec-edgar","filing":"0001437749-23-005270","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923005270/rdgdoc.xml","form_type":"4"}},{"id":1981065,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-03T01:27:16.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":4198,"source":{"system":"sec-edgar","filing":"0001437749-23-005268","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923005268/rdgdoc.xml","form_type":"4"}},{"id":1981063,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110229,"kind":"person","name":"Curtis Eric","position":1,"cik":"0001651755","reported_name":"Curtis Eric","relationship":{"officer":true,"officer_title":"SVP & COO"}}],"security":"Common Stock","published_at":"2023-03-03T01:26:25.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":1253,"source":{"system":"sec-edgar","filing":"0001437749-23-005267","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923005267/rdgdoc.xml","form_type":"4"}},{"id":1981062,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":116186,"kind":"person","name":"CARMAN DIANE","position":1,"cik":"0001871113","reported_name":"CARMAN DIANE","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2023-03-03T01:25:02.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":1227,"source":{"system":"sec-edgar","filing":"0001437749-23-005266","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923005266/rdgdoc.xml","form_type":"4"}},{"id":1996950,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":2224616,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":2224616,"derivative":{"exercise_price":0.2152,"exercise_date":"2023-08-21","expiration_date":"2028-08-21","underlying":"Common Stock","underlying_shares":2224616},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996949,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"other","acquired":false,"shares":1112308,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.1411,"exercise_date":"2023-02-22","expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":1112308},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996948,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":1112308,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":1112308,"derivative":{"exercise_price":0.1411,"exercise_date":"2023-02-22","expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":1112308},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996947,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":12,"exercise_date":"2019-01-02","expiration_date":"2023-07-02","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996946,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":498008,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":12.15,"exercise_date":"2018-12-24","expiration_date":"2023-12-24","underlying":"Common Stock","underlying_shares":498008},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996945,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":275938,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":12.09,"exercise_date":"2020-06-06","expiration_date":"2024-12-06","underlying":"Common Stock","underlying_shares":275938},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996944,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to purchase)","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":275862,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":7.975,"exercise_date":"2020-05-22","expiration_date":"2025-05-22","underlying":"Common Stock","underlying_shares":275862},"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":1996943,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:30:23.000Z","date":"2023-02-22","kind":"other","acquired":true,"shares":1112308,"price":0.1411,"value":156946.6588,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held by Panacea Venture Healthcare Fund I L.P. (\"Panacea Healthcare\"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":3449161,"source":{"system":"sec-edgar","filing":"0000899243-23-005992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000089924323005992/doc4.xml","form_type":"4"}},{"id":2201465,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-27T20:20:55.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":2500,"price":0.3799,"value":949.75,"ownership":{"direct":true},"balance_after":226558,"source":{"system":"sec-edgar","filing":"0001437749-22-017890","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922017890/rdgdoc.xml","form_type":"4"}},{"id":2202039,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":54595,"kind":"person","name":"Hamill John P.","position":1,"cik":"0001716213","reported_name":"Hamill John P.","relationship":{"officer":true,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2022-07-26T20:38:04.000Z","date":"2022-07-26","kind":"purchase","acquired":true,"shares":3000,"price":0.3666,"value":1099.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $0.3639 to $0.37. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":72800,"source":{"system":"sec-edgar","filing":"0001437749-22-017793","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922017793/rdgdoc.xml","form_type":"4"}},{"id":2202038,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-26T20:37:01.000Z","date":"2022-07-26","kind":"purchase","acquired":true,"shares":2500,"price":0.374,"value":935.0,"ownership":{"direct":true},"balance_after":224058,"source":{"system":"sec-edgar","filing":"0001437749-22-017791","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922017791/rdgdoc.xml","form_type":"4"}},{"id":2215605,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-05T20:40:55.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":4500,"price":0.4279,"value":1925.55,"ownership":{"direct":true},"balance_after":221558,"source":{"system":"sec-edgar","filing":"0001437749-22-016607","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922016607/rdgdoc.xml","form_type":"4"}},{"id":2218900,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-30T10:59:36.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":7000,"price":0.4154,"value":2907.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $0.4115 to $0.4200. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":217058,"source":{"system":"sec-edgar","filing":"0001437749-22-016227","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922016227/rdgdoc.xml","form_type":"4"}},{"id":2238213,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T00:22:52.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":0.47,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-22-014722","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014722/rdgdoc.xml","form_type":"4"}},{"id":2238212,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-10T00:22:52.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001437749-22-014722","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014722/rdgdoc.xml","form_type":"4"}},{"id":2238211,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110230,"kind":"person","name":"SCOTT ROBERT A","position":1,"cik":"0001248520","reported_name":"SCOTT ROBERT A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T00:19:05.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":0.47,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-22-014719","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014719/rdgdoc.xml","form_type":"4"}},{"id":2238210,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110230,"kind":"person","name":"SCOTT ROBERT A","position":1,"cik":"0001248520","reported_name":"SCOTT ROBERT A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-10T00:19:05.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001437749-22-014719","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014719/rdgdoc.xml","form_type":"4"}},{"id":2238209,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T00:16:06.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":0.47,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-22-014716","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014716/rdgdoc.xml","form_type":"4"}},{"id":2238208,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-10T00:16:06.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":296281,"source":{"system":"sec-edgar","filing":"0001437749-22-014716","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014716/rdgdoc.xml","form_type":"4"}},{"id":2238207,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":90815,"kind":"person","name":"Geffken Daniel E.","position":1,"cik":"0001314756","reported_name":"Geffken Daniel E.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T00:13:42.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":0.47,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-22-014714","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014714/rdgdoc.xml","form_type":"4"}},{"id":2238206,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":90815,"kind":"person","name":"Geffken Daniel E.","position":1,"cik":"0001314756","reported_name":"Geffken Daniel E.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-10T00:13:42.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date."}],"balance_after":7069,"source":{"system":"sec-edgar","filing":"0001437749-22-014714","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922014714/rdgdoc.xml","form_type":"4"}},{"id":2328919,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-17T21:33:40.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":2000,"price":0.9799,"value":1959.8,"ownership":{"direct":true},"balance_after":210058,"source":{"system":"sec-edgar","filing":"0001437749-22-006612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922006612/rdgdoc.xml","form_type":"4"}},{"id":2334094,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:48:25.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":5000,"price":0.9998,"value":4999.0,"ownership":{"direct":true},"balance_after":83602,"source":{"system":"sec-edgar","filing":"0001437749-22-006317","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922006317/rdgdoc.xml","form_type":"4"}},{"id":2334093,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-15T20:45:36.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":3000,"price":0.9801,"value":2940.3,"ownership":{"direct":true},"balance_after":208058,"source":{"system":"sec-edgar","filing":"0001437749-22-006313","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922006313/rdgdoc.xml","form_type":"4"}},{"id":2348703,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T22:53:59.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":99600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":99600,"derivative":{"exercise_price":1.02,"exercise_date":"2022-05-31","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":99600},"source":{"system":"sec-edgar","filing":"0001437749-22-005424","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005424/rdgdoc.xml","form_type":"4"}},{"id":2348702,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-07T22:53:59.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":66300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":78602,"source":{"system":"sec-edgar","filing":"0001437749-22-005424","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005424/rdgdoc.xml","form_type":"4"}},{"id":2348701,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":54595,"kind":"person","name":"Hamill John P.","position":1,"cik":"0001716213","reported_name":"Hamill John P.","relationship":{"officer":true,"officer_title":"SVP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T22:52:35.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":99600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":99600,"derivative":{"exercise_price":1.02,"exercise_date":"2022-05-31","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":99600},"source":{"system":"sec-edgar","filing":"0001437749-22-005421","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005421/rdgdoc.xml","form_type":"4"}},{"id":2348700,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":54595,"kind":"person","name":"Hamill John P.","position":1,"cik":"0001716213","reported_name":"Hamill John P.","relationship":{"officer":true,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2022-03-07T22:52:35.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":66300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":69800,"source":{"system":"sec-edgar","filing":"0001437749-22-005421","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005421/rdgdoc.xml","form_type":"4"}},{"id":2348699,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T22:51:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":250400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":250400,"derivative":{"exercise_price":1.02,"exercise_date":"2022-05-31","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":250400},"source":{"system":"sec-edgar","filing":"0001437749-22-005417","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005417/rdgdoc.xml","form_type":"4"}},{"id":2348698,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-07T22:51:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":166900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":205058,"source":{"system":"sec-edgar","filing":"0001437749-22-005417","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005417/rdgdoc.xml","form_type":"4"}},{"id":2348696,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110229,"kind":"person","name":"Curtis Eric","position":1,"cik":"0001651755","reported_name":"Curtis Eric","relationship":{"officer":true,"officer_title":"SVP & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T22:48:59.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":99600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":99600,"derivative":{"exercise_price":1.02,"exercise_date":"2022-05-31","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":99600},"source":{"system":"sec-edgar","filing":"0001437749-22-005414","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005414/rdgdoc.xml","form_type":"4"}},{"id":2348695,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110229,"kind":"person","name":"Curtis Eric","position":1,"cik":"0001651755","reported_name":"Curtis Eric","relationship":{"officer":true,"officer_title":"SVP & COO"}}],"security":"Common Stock","published_at":"2022-03-07T22:48:59.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":66300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":67591,"source":{"system":"sec-edgar","filing":"0001437749-22-005414","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005414/rdgdoc.xml","form_type":"4"}},{"id":2348694,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":116186,"kind":"person","name":"CARMAN DIANE","position":1,"cik":"0001871113","reported_name":"CARMAN DIANE","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T22:47:20.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":99600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":99600,"derivative":{"exercise_price":1.02,"exercise_date":"2022-05-31","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":99600},"source":{"system":"sec-edgar","filing":"0001437749-22-005412","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005412/rdgdoc.xml","form_type":"4"}},{"id":2348693,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":116186,"kind":"person","name":"CARMAN DIANE","position":1,"cik":"0001871113","reported_name":"CARMAN DIANE","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-07T22:47:20.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":66300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":66300,"source":{"system":"sec-edgar","filing":"0001437749-22-005412","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005412/rdgdoc.xml","form_type":"4"}},{"id":2439293,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131517,"kind":"organization","name":"Center Laboratories, Inc.","position":1,"cik":"0001770423","reported_name":"Center Laboratories, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"SERIES J WARRANTS","published_at":"2022-01-10T22:03:57.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":55172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Bioengine Capital Inc."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"The Series G and Series J Warrants are directly held by Bioengine Capital Inc. and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc."}],"balance_after":55172,"derivative":{"exercise_price":7.795,"exercise_date":"2022-05-22","expiration_date":"2025-05-22","underlying":"Common Stock","underlying_shares":55172},"source":{"system":"sec-edgar","filing":"0001213900-22-001391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001391/ownership.xml","form_type":"4"}},{"id":2439292,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131517,"kind":"organization","name":"Center Laboratories, Inc.","position":1,"cik":"0001770423","reported_name":"Center Laboratories, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"SERIES G WARRANTS","published_at":"2022-01-10T22:03:57.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":249004,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Bioengine Capital Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person voluntarily discloses that, on May 20, 2020, in connection with the Reverse Stock Split, the Issuer effected a 1-for-3 reverse split of all of its issued and outstanding Series G Warrants, which resulted in the Reporting Person's beneficial ownership of Series G Warrants being reduced from 747,012 shares of Series G Warrants to 249,004 shares of Series G Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The exercise of the Series G Warrants is subject to a beneficial ownership limitation of 9.99%, and this limitation can only be changed with effect from the 61st day after a notice requesting such change is delivered to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person voluntarily discloses that, on May 20, 2020, in connection with the Reverse Stock Split, the Issuer effected a 1-for-3 reverse split of all of its issued and outstanding Series G Warrants, which resulted in the Reporting Person's beneficial ownership of Series G Warrants being reduced from 747,012 shares of Series G Warrants to 249,004 shares of Series G Warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"The Series G and Series J Warrants are directly held by Bioengine Capital Inc. and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc."}],"balance_after":249004,"derivative":{"exercise_price":12.15,"exercise_date":"2018-12-24","expiration_date":"2023-12-24","underlying":"Common Stock","underlying_shares":249004},"source":{"system":"sec-edgar","filing":"0001213900-22-001391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001391/ownership.xml","form_type":"4"}},{"id":2439291,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131517,"kind":"organization","name":"Center Laboratories, Inc.","position":1,"cik":"0001770423","reported_name":"Center Laboratories, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"SERIES F WARRANTS","published_at":"2022-01-10T22:03:57.000Z","date":"2020-06-24","kind":"other","acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Bioengine Capital Inc."},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. The Series F Warrants were directly held by Bioengine Capital Inc. and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc. As a result, the Reporting Person currently indirectly owns 0 shares of Series F Warrants."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. The Series F Warrants were directly held by Bioengine Capital Inc. and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc. As a result, the Reporting Person currently indirectly owns 0 shares of Series F Warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. The Series F Warrants were directly held by Bioengine Capital Inc. and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc. As a result, the Reporting Person currently indirectly owns 0 shares of Series F Warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. The Series F Warrants were directly held by Bioengine Capital Inc. and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc. As a result, the Reporting Person currently indirectly owns 0 shares of Series F Warrants."}],"balance_after":0,"derivative":{"exercise_price":3.68,"exercise_date":"2018-12-24","expiration_date":"2020-06-24","underlying":"Common Stock","underlying_shares":384824},"source":{"system":"sec-edgar","filing":"0001213900-22-001391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001391/ownership.xml","form_type":"4"}},{"id":2439290,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131517,"kind":"organization","name":"Center Laboratories, Inc.","position":1,"cik":"0001770423","reported_name":"Center Laboratories, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T22:03:57.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":1239088,"price":1.6,"value":1982540.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 30, 2021, the Reporting Person purchased all remaining shares of Common Stock held by Bioengine Capital Inc., and now holds the shares directly."}],"balance_after":1239088,"source":{"system":"sec-edgar","filing":"0001213900-22-001391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001391/ownership.xml","form_type":"4"}},{"id":2439289,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131517,"kind":"organization","name":"Center Laboratories, Inc.","position":1,"cik":"0001770423","reported_name":"Center Laboratories, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T22:03:57.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":55172,"price":7.25,"value":399997.0,"ownership":{"direct":false,"nature":"By Bioengine Capital Inc."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares of Common Stock are directly held by Bioengine Capital Inc, and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc."}],"balance_after":1239088,"source":{"system":"sec-edgar","filing":"0001213900-22-001391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001391/ownership.xml","form_type":"4"}},{"id":2439288,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131517,"kind":"organization","name":"Center Laboratories, Inc.","position":1,"cik":"0001770423","reported_name":"Center Laboratories, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T22:03:57.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":3551750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Bioengine Capital Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person voluntarily discloses that, on May 20, 2020, the Issuer effected a 1-for-3 reverse stock split of its Common Stock (the \"Reverse Stock Split\"), which resulted in the Reporting Person's beneficial ownership of issued and outstanding Common Stock being reduced from 3,551,750 shares of Common Stock to 1,183,916 shares of Common Stock. The shares of Common Stock are directly held by Bioengine Capital Inc., and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares of Common Stock are directly held by Bioengine Capital Inc, and indirectly held by the Reporting Person, which owns 58.6% of Bioengine Capital Inc."}],"balance_after":1183916,"source":{"system":"sec-edgar","filing":"0001213900-22-001391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001391/ownership.xml","form_type":"4"}},{"id":2439287,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131516,"kind":"organization","name":"Bioengine Capital Inc.","position":1,"cik":"0001770197","reported_name":"Bioengine Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"SERIES J WARRANTS","published_at":"2022-01-10T22:03:07.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":55172,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55172,"derivative":{"exercise_price":7.975,"exercise_date":"2020-05-22","expiration_date":"2025-05-22","underlying":"Common Stock","underlying_shares":55172},"source":{"system":"sec-edgar","filing":"0001213900-22-001390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001390/ownership.xml","form_type":"4"}},{"id":2439286,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131516,"kind":"organization","name":"Bioengine Capital Inc.","position":1,"cik":"0001770197","reported_name":"Bioengine Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"SERIES G WARRANTS","published_at":"2022-01-10T22:03:07.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":249004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person voluntarily discloses that, on May 20, 2020, in connection with the Reverse Stock Split, the Issuer effected a 1-for-3 reverse split of all of its issued and outstanding Series G Warrants, which resulted in the Reporting Person's ownership of Series G Warrants being reduced from 747,012 shares of Series G Warrants to 249,004 shares of Series G Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The exercise of the Series G Warrants is subject to a beneficial ownership limitation of 9.99% and this limitation can only be changed with effect from the 61st day after a notice requesting such change is delivered to the Issuer."}],"balance_after":249004,"derivative":{"exercise_price":12.15,"exercise_date":"2018-12-24","expiration_date":"2023-12-24","underlying":"Common Stock","underlying_shares":249004},"source":{"system":"sec-edgar","filing":"0001213900-22-001390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001390/ownership.xml","form_type":"4"}},{"id":2439285,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131516,"kind":"organization","name":"Bioengine Capital Inc.","position":1,"cik":"0001770197","reported_name":"Bioengine Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"SERIES F WARRANTS","published_at":"2022-01-10T22:03:07.000Z","date":"2020-06-24","kind":"other","acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. As a result, the Reporting Person now directly owns 0 shares of Series F Warrants."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. As a result, the Reporting Person now directly owns 0 shares of Series F Warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. As a result, the Reporting Person now directly owns 0 shares of Series F Warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The Reporting Person voluntarily discloses that, on July 24, 2020, Series F Warrants had expired. As a result, the Reporting Person now directly owns 0 shares of Series F Warrants."}],"balance_after":0,"derivative":{"exercise_price":3.68,"exercise_date":"2018-12-24","expiration_date":"2020-06-24","underlying":"Common Stock","underlying_shares":384824},"source":{"system":"sec-edgar","filing":"0001213900-22-001390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001390/ownership.xml","form_type":"4"}},{"id":2439284,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131516,"kind":"organization","name":"Bioengine Capital Inc.","position":1,"cik":"0001770197","reported_name":"Bioengine Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T22:03:07.000Z","date":"2021-12-30","kind":"sale","acquired":false,"shares":1239088,"price":1.6,"value":1982540.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 30, 2021, the Reporting Person sold all its remaining shares of Common Stock to Center Laboratories, Inc., which owns 58.6% of the Reporting Person. As a result of the foregoing transaction, the Reporting Person now directly owns 0 shares of Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"On December 30, 2021, the Reporting Person sold all its remaining shares of Common Stock to Center Laboratories, Inc., which owns 58.6% of the Reporting Person. As a result of the foregoing transaction, the Reporting Person now directly owns 0 shares of Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-001390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001390/ownership.xml","form_type":"4"}},{"id":2439283,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131516,"kind":"organization","name":"Bioengine Capital Inc.","position":1,"cik":"0001770197","reported_name":"Bioengine Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T22:03:07.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":55172,"price":7.25,"value":399997.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares were directly held by the Reporting Person and indirectly held by Center Laboratories, Inc., which owns 58.6% of the Reporting Person."}],"balance_after":1239088,"source":{"system":"sec-edgar","filing":"0001213900-22-001390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001390/ownership.xml","form_type":"4"}},{"id":2439282,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":131516,"kind":"organization","name":"Bioengine Capital Inc.","position":1,"cik":"0001770197","reported_name":"Bioengine Capital Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T22:03:07.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":3551750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person voluntarily discloses that, on May 20, 2020, the Issuer effected a 1-for-3 reverse stock split of its Common Stock (the \"Reverse Stock Split\"), which resulted in the Reporting Person's ownership of issued and outstanding Common Stock being reduced from 3,551,750 shares of Common Stock to 1,183,916 shares of Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares were directly held by the Reporting Person and indirectly held by Center Laboratories, Inc., which owns 58.6% of the Reporting Person."}],"balance_after":1183916,"source":{"system":"sec-edgar","filing":"0001213900-22-001390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000121390022001390/ownership.xml","form_type":"4"}},{"id":2501473,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T13:35:54.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":930,"price":1.6,"value":1488.0,"ownership":{"direct":true},"balance_after":38158,"source":{"system":"sec-edgar","filing":"0001437749-21-027198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921027198/rdgdoc.xml","form_type":"4"}},{"id":2505430,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-18T21:25:25.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":930,"price":1.61,"value":1497.3,"ownership":{"direct":true},"balance_after":37228,"source":{"system":"sec-edgar","filing":"0001437749-21-027085","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921027085/rdgdoc.xml","form_type":"4"}},{"id":2535799,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T13:17:43.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":3000,"price":1.9,"value":5700.0,"ownership":{"direct":true},"balance_after":36298,"source":{"system":"sec-edgar","filing":"0001437749-21-024196","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921024196/rdgdoc.xml","form_type":"4"}},{"id":2539854,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:56:06.000Z","date":"2021-10-19","kind":"purchase","acquired":true,"shares":50000,"price":1.9027,"value":95135.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $1.84 to $1.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":291281,"source":{"system":"sec-edgar","filing":"0001437749-21-023912","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921023912/rdgdoc.xml","form_type":"4"}},{"id":2539853,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-19T20:51:46.000Z","date":"2021-10-19","kind":"purchase","acquired":true,"shares":3000,"price":1.91,"value":5730.0,"ownership":{"direct":true},"balance_after":33298,"source":{"system":"sec-edgar","filing":"0001437749-21-023910","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921023910/rdgdoc.xml","form_type":"4"}},{"id":2642111,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":116186,"kind":"person","name":"CARMAN DIANE","position":1,"cik":"0001871113","reported_name":"CARMAN DIANE","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T20:05:26.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date.  The stock option is an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4)."}],"balance_after":150000,"derivative":{"exercise_price":2.27,"exercise_date":"2022-07-01","expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-21-016434","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921016434/rdgdoc.xml","form_type":"4"}},{"id":2664802,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-18T00:03:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.28,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-015119","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921015119/rdgdoc.xml","form_type":"4"}},{"id":2664801,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":90815,"kind":"person","name":"Geffken Daniel E.","position":1,"cik":"0001314756","reported_name":"Geffken Daniel E.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-18T00:02:54.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.28,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-015118","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921015118/rdgdoc.xml","form_type":"4"}},{"id":2744332,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-20T11:44:42.000Z","date":"2021-04-16","kind":"purchase","acquired":true,"shares":1000,"price":2.092,"value":2092.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $2.09 to $2.0933. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30298,"source":{"system":"sec-edgar","filing":"0001437749-21-009306","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921009306/rdgdoc.xml","form_type":"4"}},{"id":2745959,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":54595,"kind":"person","name":"Hamill John P.","position":1,"cik":"0001716213","reported_name":"Hamill John P.","relationship":{"officer":true,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2021-04-19T11:49:12.000Z","date":"2021-04-16","kind":"purchase","acquired":true,"shares":1000,"price":2.0669,"value":2066.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $2.065 to $2.0685. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001437749-21-009187","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921009187/rdgdoc.xml","form_type":"4"}},{"id":2745958,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-19T11:47:53.000Z","date":"2021-04-15","kind":"purchase","acquired":true,"shares":1000,"price":2.2399,"value":2239.9,"ownership":{"direct":true},"balance_after":29298,"source":{"system":"sec-edgar","filing":"0001437749-21-009186","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921009186/rdgdoc.xml","form_type":"4"}},{"id":2753414,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110229,"kind":"person","name":"Curtis Eric","position":1,"cik":"0001651755","reported_name":"Curtis Eric","relationship":{"officer":true,"officer_title":"SVP & COO"}}],"security":"Common Stock","published_at":"2021-04-08T20:16:46.000Z","date":"2021-04-07","kind":"purchase","acquired":true,"shares":791,"price":2.5172,"value":1991.1052,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $2.515 to $2.5185. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001437749-21-008559","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008559/rdgdoc.xml","form_type":"4"}},{"id":2754787,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-07T20:18:26.000Z","date":"2021-04-06","kind":"purchase","acquired":true,"shares":500,"price":2.57,"value":1285.0,"ownership":{"direct":true},"balance_after":28298,"source":{"system":"sec-edgar","filing":"0001437749-21-008459","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008459/rdgdoc.xml","form_type":"4"}},{"id":2756133,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-06T20:28:13.000Z","date":"2021-04-05","kind":"purchase","acquired":true,"shares":1000,"price":2.5799,"value":2579.9,"ownership":{"direct":true},"balance_after":27798,"source":{"system":"sec-edgar","filing":"0001437749-21-008400","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008400/rdgdoc.xml","form_type":"4"}},{"id":2758966,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T12:06:27.000Z","date":"2021-04-01","kind":"purchase","acquired":true,"shares":500,"price":2.4587,"value":1229.35,"ownership":{"direct":true},"balance_after":26798,"source":{"system":"sec-edgar","filing":"0001437749-21-008159","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008159/rdgdoc.xml","form_type":"4"}},{"id":2762460,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-04-02T21:13:54.000Z","date":"2021-03-31","kind":"purchase","acquired":true,"shares":150000,"price":2.36,"value":354000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $2.275 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171000,"source":{"system":"sec-edgar","filing":"0001437749-21-008134","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008134/rdgdoc.xml","form_type":"4"}},{"id":2767099,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-31T20:30:02.000Z","date":"2021-03-31","kind":"purchase","acquired":true,"shares":500,"price":2.3199,"value":1159.95,"ownership":{"direct":true},"balance_after":26298,"source":{"system":"sec-edgar","filing":"0001437749-21-007852","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007852/rdgdoc.xml","form_type":"4"}},{"id":2772412,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock Warrants","published_at":"2021-03-25T20:45:24.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above."}],"balance_after":1500,"derivative":{"exercise_price":3.6,"exercise_date":"2021-03-25","expiration_date":"2026-03-25","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-21-007173","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007173/rdgdoc.xml","form_type":"4"}},{"id":2772411,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":88810,"kind":"person","name":"Simonson Steven","position":1,"cik":"0001624401","reported_name":"Simonson Steven","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-25T20:45:24.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":3.25,"value":4875.0,"ownership":{"direct":true},"balance_after":12302,"source":{"system":"sec-edgar","filing":"0001437749-21-007173","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007173/rdgdoc.xml","form_type":"4"}},{"id":2772414,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":54595,"kind":"person","name":"Hamill John P.","position":1,"cik":"0001716213","reported_name":"Hamill John P.","relationship":{"officer":true,"officer_title":"SVP & CFO"}}],"security":"Common Stock Warrants","published_at":"2021-03-25T20:44:17.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above."}],"balance_after":1500,"derivative":{"exercise_price":3.6,"exercise_date":"2021-03-25","expiration_date":"2026-03-25","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-21-007172","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007172/rdgdoc.xml","form_type":"4"}},{"id":2772413,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":54595,"kind":"person","name":"Hamill John P.","position":1,"cik":"0001716213","reported_name":"Hamill John P.","relationship":{"officer":true,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2021-03-25T20:44:17.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":3.25,"value":4875.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001437749-21-007172","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007172/rdgdoc.xml","form_type":"4"}},{"id":2772410,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants","published_at":"2021-03-25T20:43:13.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above."}],"balance_after":1500,"derivative":{"exercise_price":3.6,"exercise_date":"2021-03-25","expiration_date":"2026-03-25","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-21-007171","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007171/rdgdoc.xml","form_type":"4"}},{"id":2772409,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-25T20:43:13.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":3.25,"value":4875.0,"ownership":{"direct":true},"balance_after":25798,"source":{"system":"sec-edgar","filing":"0001437749-21-007171","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007171/rdgdoc.xml","form_type":"4"}},{"id":2872863,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":110230,"kind":"person","name":"SCOTT ROBERT A","position":1,"cik":"0001248520","reported_name":"SCOTT ROBERT A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T21:25:49.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":30000,"derivative":{"exercise_price":5.5,"exercise_date":"2022-02-03","expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-21-002339","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921002339/rdgdoc.xml","form_type":"4"}},{"id":2877806,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":137997,"kind":"person","name":"PEACOCK BRUCE","position":1,"cik":"0001228459","reported_name":"PEACOCK BRUCE","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-06T02:14:43.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"exercise_date":"2021-02-03","expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-002149","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921002149/rdgdoc.xml","form_type":"4"}},{"id":2877805,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-06T02:13:13.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"exercise_date":"2021-02-03","expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-002148","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921002148/rdgdoc.xml","form_type":"4"}},{"id":2877804,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":90815,"kind":"person","name":"Geffken Daniel E.","position":1,"cik":"0001314756","reported_name":"Geffken Daniel E.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-06T02:11:52.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest as follows: 1/3 vested immediately on the grant date, 1/3 shall vest on the first anniversary of the grant date and 1/3 shall vest on the second anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"exercise_date":"2021-02-03","expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-002147","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921002147/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2021-02-06T02:11:52.000000Z,2877804"}